SCHEMBL4823642

SCHEMBL4823642

Cc1ccc(N(C)CC2(N(C)C(=O)O)CC2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.34
KDM1A O60341 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
OPRM1 P35372 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ELANE P08246 1/20 0.31
POLB P06746 1/20 0.31
ALDH1A1 P00352 1/20 0.31
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4824088 0.85 MEN1 (0.39) SMN1; SMN2MEN1KMT2ATDP1POLB
SCHEMBL4820601 0.85 OXTR (0.31) RXRARXRBRXRG
SCHEMBL3776471 0.76 PDE3B (0.36) ALDH1A1KDM4E
SCHEMBL6482943 0.76 CYP4F2 (0.39) KMT2A
SCHEMBL3151465 0.75 ABL1 (0.35)
SCHEMBL4817839 0.75 GRM5 (0.39) SMN1; SMN2HDAC1HDAC6OPRM1ALDH1A1
SCHEMBL3141927 0.74 CYP11B1 (0.32) ALDH1A1
SCHEMBL3147249 0.72 HTT (0.36) TSHRSMN1; SMN2OPRM1MEN1KMT2A
SCHEMBL4669413 0.71 KDM1A (0.35) KDM1A
SCHEMBL4825679 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080146621-A1 Polysubstituted 1,1-pyridylaminocyclopropanamine compounds LES LABORATORIES SERVIER (FR) 2008-06-19 US disclosed
US-7388022-B2 Polysubstituted 1,1-pyridylaminocyclopropanamine compounds LES LABORATOIRES SERVIER (FR) 2008-06-17 US disclosed
US-20070027192-A1 Polysubstituted 1,1-pyridylamioncyclopropanamine compounds LES LABORATOIRES SERVIER (FR) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146621-A1 Polysubstituted 1,1-pyridylaminocyclopropanamine compounds CHRNA1, CHRM1, CHRNA9 IDO1 1353/4885KDM1A 2602/4885TSHR 138/4885
US-20070027192-A1 Polysubstituted 1,1-pyridylamioncyclopropanamine compounds CHRM1, CHRM2, CHRM3 IDO1 1753/4885KDM1A 3421/4885TSHR 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.